Kamada (KMDA) Cash & Current Investments (2012 - 2026)

Kamada (KMDA) posted quarterly Cash & Current Investments of $73.1 million for Q1 2026, down 4.07% year-on-year from $76.2 million in Q1 2025, and down 3.33% on a QoQ basis from $75.7 million in Q4 2025.

Kamada (KMDA) Cash & Current Investments (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Cash & Current Investments for 15 consecutive years, with $73.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Current Investments fell 4.07% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.1 million (down 4.07% YoY) and the FY2025 annual result came in at $75.7 million, down 3.59% from the prior year.
  • Cash & Current Investments slipped to $73.1 million in Q1 2026 per KMDA's latest filing, from $75.7 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for KMDA reached as high as $31.3 billion in Q3 2022 and fell as low as $29933.0 in Q2 2022.
  • A 5-year average of $1.9 billion and a median of $56.5 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments sank 99.97% — and 2023, when it jumped 72689.23%.
  • Year by year, Cash & Current Investments stood at $34.3 million in 2022, then soared by 62.83% to $55.8 million in 2023, then jumped by 40.68% to $78.5 million in 2024, then slipped by 3.59% to $75.7 million in 2025, then fell by 3.33% to $73.1 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $73.1 million, $75.7 million, and $72.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 91.93 Bn 90.07 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 36.31 Bn 32.57 Bn 1.97 Bn 3.74 Bn
3 Zoetis 33.01 Bn 31.07 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.65 Bn 23.59 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.96 Bn 20.81 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.50 Bn 18.69 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 18.16 Bn 16.85 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.84 Bn 12.41 Bn 785.00 Mn 428.00 Mn
10 Kamada 403.42 Mn 330.27 Mn 19.12 Mn 73.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 73.15 Mn
Dec 31, 2025 75.67 Mn
Sep 30, 2025 72.00 Mn
Jun 30, 2025 65.99 Mn
Mar 31, 2025 76.25 Mn
Dec 31, 2024 78.48 Mn
Sep 30, 2024 72.00 Mn
Jun 30, 2024 56.55 Mn
Mar 31, 2024 48.19 Mn
Dec 31, 2023 55.79 Mn
Sep 30, 2023 52.60 Mn
Jun 30, 2023 21.79 Mn
Mar 31, 2023 27.12 Mn
Dec 31, 2022 34.26 Mn
Sep 30, 2022 31.25 Bn
Jun 30, 2022 29,933.00
Mar 31, 2022 21.97 Mn
Dec 31, 2021 145.29 Mn
Sep 30, 2021 99.84 Mn
Jun 30, 2021 104.55 Mn